Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.75
-0.15 (-2.54%)
At close: Jun 27, 2025, 4:00 PM
5.76
+0.01 (0.17%)
After-hours: Jun 27, 2025, 7:31 PM EDT
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of $294.15 million as of June 27, 2025. Its market cap has increased by 60.13% in one year.
Market Cap
294.15M
Enterprise Value
235.25M
1-Year Change
60.13%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $294.15M, an increase of 277.12%. That is a compound annual growth rate of 5.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 301.80M | 24.66% |
Dec 31, 2024 | 242.10M | 95.08% |
Dec 29, 2023 | 124.10M | 134.59% |
Dec 30, 2022 | 52.90M | 54.23% |
Dec 31, 2021 | 34.30M | -77.83% |
Dec 31, 2020 | 154.70M | -7.53% |
Dec 31, 2019 | 167.30M | -51.12% |
Dec 31, 2018 | 342.30M | -53.83% |
Dec 29, 2017 | 741.40M | 282.56% |
Dec 30, 2016 | 193.80M | 76.18% |
Dec 31, 2015 | 110.00M | 5,689.47% |
Dec 31, 2014 | 1.90M | -70.31% |
Dec 31, 2013 | 6.40M | 10.34% |
Dec 31, 2012 | 5.80M | -82.63% |
Dec 30, 2011 | 33.40M | -15.87% |
Dec 31, 2010 | 39.70M | -7.89% |
Dec 31, 2009 | 43.10M | 563.08% |
Dec 31, 2008 | 6.50M | -43.97% |
Dec 31, 2007 | 11.60M | 17.17% |
Dec 29, 2006 | 9.90M | 7.61% |
Dec 30, 2005 | 9.20M | -83.24% |
Dec 31, 2004 | 54.90M | -21.57% |
Dec 31, 2003 | 70.00M | 255.33% |
Dec 31, 2002 | 19.70M | -65.50% |
Dec 31, 2001 | 57.10M | -10.64% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 713.81B |
Johnson & Johnson | 365.75B |
AbbVie | 329.95B |
Novo Nordisk | 299.93B |
UnitedHealth Group | 274.52B |
Novartis AG | 235.02B |
Abbott Laboratories | 232.56B |
AstraZeneca | 215.99B |